Global United Pharmaceutical Corporation Report issue

For profit Phase 2
Founded: Wilmington DE United States (2013)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2014
NCT02153541
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

antipyrine (1 trial)

benzocaine (Orajel) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3